ScholarIQanswers from OpenAlex & ORCID
Fatemeh Chalabianloo
ResearcherPublications, citations & collaboration network
Fatemeh Chalabianloo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Fatemeh Chalabianloo have?
ScholarIQindexed works
Fatemeh Chalabianloo has 73 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fatemeh Chalabianloo have?
ScholarIQcitation count
Fatemeh Chalabianloo has 618 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Fatemeh Chalabianloo?
ScholarIQh-index
Fatemeh Chalabianloo has an h-index of 14 in OpenAlex.
What is the i10-index of Fatemeh Chalabianloo?
ScholarIQi10-index
Fatemeh Chalabianloo has an i10-index of 20 in OpenAlex.
What is the ORCID of Fatemeh Chalabianloo?
ScholarIQorcid
The ORCID for Fatemeh Chalabianloo is on the source record.
What is the OpenAlex record for Fatemeh Chalabianloo?
ScholarIQopenalex
The OpenAlex for Fatemeh Chalabianloo is on the source record.
What are the most-cited papers on Fatemeh Chalabianloo?
ScholarIQmost cited works
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
Lars Thore Fadnes, Christer Frode, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else‐Marie Løberg, Kjell Arne Johansson, for the INTRO-HCV Study Group
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
for the INTRO-HCV Study Group, Lars Thore Fadnes, Christer Frode, Jørn Henrik Vold, Christian Ohldieck, Rafael Alexander Leiva, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else‐Marie Løberg, Kjell Arne Johansson
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
Christer Frode, Jørn Henrik Vold, Svetlana Skurtveit, Aaron G. Lim, Sabine Ruths, M. Kamrul Islam, Jan Erik Askildsen, Else‐Marie Løberg, Lars Thore Fadnes, Kjell Arne Johansson, for the INTRO-HCV Study Group, Christer Frode, Vibeke Bråthen Buljovcic, Fatemeh Chalabianloo, Jan Tore Daltveit, Silvia Eiken Alpers, Lars Thore Fadnes, Trude Fondenes Eriksen, Per Gundersen, Velinda Hille, Kristin Holmelid Håberg, Kjell Arne Johansson, Rafael Alexander Leiva, Siv-Elin Leirvåg Carlsen, Martine Lepsøy Bonnier, Lennart Lorås, Else‐Marie Løberg, Mette Hegland Nordbotn, Cathrine Nygård, Maria Olsvold, Christian Ohldieck, Lillian Sivertsen, Hugo Torjussen, Jørn Henrik Vold, Jan-Magnus Økland, Tone Lise Eielsen, Nancy Laura Ortega Maldonado, Ewa Joanna Wilk, Ronny Bjørnestad, Ole Jørgen Lygren, Marianne Cook Pierron, Olav Dalgård, Håvard Midgard, Svetlana Skurtveit, Peter Vickerman
Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
Jørn Henrik Vold, Christer Aas, Rafael Alexander Leiva, Peter Vickerman, Fatemeh Chalabianloo, Else‐Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes
Pregabalin og misbrukspotensial
Fatemeh Chalabianloo, J. S. Schjott